Sonic Healthcare (ASX:SHL) will acquire LADR - Laboratory Group Dr. Kramer & Colleagues in Germany for 423 million euros, according to a Monday filing with the Australian bourse.
The transaction consideration includes the issue of up to 222 million euros in Sonic Healthcare ordinary shares, the filing said. The balance will be settled via existing cash and debt facilities.
Sonic Healthcare expects the acquisition to be immediately accretive to earnings per share, reaching high single-digit percentage accretion after three years, the filing stated.
The deal is expected to close in the first half of 2025, subject to conditions and regulatory approval.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。